Our results highlight a shared neuroinflammatory signature across Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), characterized by the dysregulation of hub genes such as MMP9, S100A8, S100A9, CCL2, and LCN2. Here, MMP9 is linked to Huntington disease.